Omega Diagnostics Gp - Director/PDMR Shareholding

Cambridge Nutritional Sciences

09/05/2023 15:42

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230509:nRSI8370Ya&default-theme=true

RNS Number : 8370Y  Omega Diagnostics Group PLC  09 May 2023

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Omega (AIM: ODX), the specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and nutrition,
announces that it has received notification that Jag Grewal, Chief Executive
Officer, and Chris Lea, Chief Financial Officer, each purchased 69,498
ordinary shares of 4 pence each in the Company ("Ordinary Shares") on 5 May
2023 through the Company's all-employee Share Incentive Plan, at a price of
2.59 pence each. At the same time, these individuals were also awarded (for no
consideration) their corresponding Matching Shares under the plan.

 

A summary of each Directors resultant holdings is below:

 

 

 Director    Board Position             Number of Partnership Shares acquired under the SIP on 5 May 2023  Number of Matching Shares acquired under the SIP on 5 May 2023  Total beneficial holding of Ordinary Shares following these acquisitions
             Number of Ordinary Shares                                                                     Approximate % of Company's issued share capital
 Jag Grewal  CEO                        69,498                                                             69,498                                                          2,164,830                              0.91%
 Chris Lea   CFO                        69,498                                                             69,498                                                          2,169,904                              0.91%

 

 

Contacts:

 

 Omega Diagnostics Group PLC                            www.omegadx.com (http://www.omegadx.com/)
 Jag Grewal, Chief Executive Officer                                     via Walbrook PR
 Chris Lea, Chief Financial Officer

 finnCap Ltd                                            Tel: 020 7220 0500
 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
 Alice Lane/Charlotte Sutcliffe (ECM)

 Walbrook PR Limited  Tel: 020 7933 8780 or omega@walbrookpr.com (mailto:omega@walbrookpr.com)
 Paul McManus                          Mob: 07980 541 893
 Lianne Applegarth                     Mob: 07584 391 303
 Sam Allen                             Mob: 07502 558 258

 

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on
promoting a personalised and functional approach to health and nutrition.

www.omegadx.com (http://www.omegadx.com/)

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014. Upon the publication of this announcement via the
Regulatory Information Service, this inside information is now considered to
be in the public domain.

 

Notification of transactions of persons discharging managerial
responsibilities and persons closely associated with them

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Jag Grewal

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Omega Diagnostics Group PLC

 b)   LEI                                                          2138007U9P4BTZTYIR92

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 4 pence each

      Identification code

                                                                   ISIN: GB00B1VCP282
 b)   Nature of the transaction                                    Ordinary Shares purchased

 c)   Price(s) and volume(s)

Price(s)    Volume(s)
                                                                   2.59 pence  69,498

 d)   Aggregated information                                       See above

      -Aggregated volume

      - Price

 e)   Date of the transaction                                      05.05.2023

 f)   Place of the transaction                                     London Stock Exchange

d)

 

Aggregated information

 

 

-Aggregated volume

 

 

- Price

 

 

See above

e)

 

Date of the transaction

 

05.05.2023

f)

 

Place of the transaction

 

London Stock Exchange

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Chris Lea

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Omega Diagnostics Group PLC

 b)   LEI                                                          2138007U9P4BTZTYIR92

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 4 pence each

      Identification code

                                                                   ISIN: GB00B1VCP282
 b)   Nature of the transaction                                    Ordinary Shares purchased

 c)   Price(s) and volume(s)

Price(s)    Volume(s)
                                                                   2.59 pence  69,498

 d)   Aggregated information                                       See above

      -Aggregated volume

      - Price

 e)   Date of the transaction                                      05.05.2023

 f)   Place of the transaction                                     London Stock Exchange

d)

 

Aggregated information

 

 

-Aggregated volume

 

 

- Price

 

 

See above

e)

 

Date of the transaction

 

05.05.2023

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBSGDUDXGDGXC